TrialAnnals of the rheumatic diseases2014

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

Tom W J Huizinga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.